Log on / register
Feedback | Support | My details
A consensus prognostic gene expression classifier for ER positive breast cancer.
Teschendorff AE, Naderi A, Barbosa-Morais NL, Pinder SE, Ellis IO, Aparicio S, Brenton JD, Caldas C
Genome Biol 2006, 7:R101
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Elucidating the altered transcriptional programs in breast cancer using independent component analysis.
Teschendorff AE, Journée M, Absil PA, Sepulchre R, Caldas C
PLoS Comput Biol 2007 Aug, 3:e161
[PubMed Central] [PubMed] [Related articles]

2.
Module-based outcome prediction using breast cancer compendia.
van Vliet MH, Klijn CN, Wessels LF, Reinders MJ
PLoS One 2007, 2:e1047
[PubMed Central] [PubMed] [Related articles]

3.
ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification.
Zou JX, Revenko AS, Li LB, Gemo AT, Chen HW
Proc Natl Acad Sci U S A 2007 Nov 13, 104:18067-72
[PubMed Central] [PubMed] [Related articles]

4.
Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets.
Martin KJ, Patrick DR, Bissell MJ, Fournier MV
PLoS One 2008, 3:e2994
[PubMed Central] [PubMed] [Related articles]


This article is also cited by 16 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.